These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2880804)

  • 1. Is beta 1-antagonism essential for the antihypertensive action of beta-blockers?
    Vincent HH; Man in 't Veld AJ; Boomsma F; Derkx FH; Schalekamp MA
    Hypertension; 1987 Feb; 9(2):198-203. PubMed ID: 2880804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound ICI 118,551, a beta 2-adrenoceptor antagonist, lowers blood pressure.
    Vincent HH; Man in 't Veld AJ; Boomsma F; Derkx F; Schalekamp MA
    J Hypertens Suppl; 1985 Dec; 3(3):S247-9. PubMed ID: 2908820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
    Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ
    Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
    Constantine GR; Ranasinghe P; Weeratunga P; Weeraratne C; Galappatthy P; Rajapakse S; Senarath U; Katulanda P
    Trials; 2017 Mar; 18(1):124. PubMed ID: 28292320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with beta-blockers.
    Mores N; Campia U; Navarra P; Cardillo C; Preziosi P
    Eur J Clin Pharmacol; 1999 Jun; 55(4):251-4. PubMed ID: 10424315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade.
    Dahlöf B; Andrén L; Svensson A; Hansson L
    J Hypertens Suppl; 1983 Dec; 1(2):112-5. PubMed ID: 6152739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking drugs in the treatment of hypertension.
    Prichard BN; Cruickshank JM; Graham BR
    Blood Press; 2001; 10(5-6):366-86. PubMed ID: 11822540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
    Maclean D
    Angiology; 1988 Jun; 39(6):487-96. PubMed ID: 2897812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 17. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atenolol and three nonselective beta-blockers in hypertension.
    Waal-Manning HJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):8-18. PubMed ID: 31259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative effects of ICI 118551 and propranolol on essential tremor.
    Jefferson D; Wharrad HJ; Birmingham AT; Patrick JM
    Br J Clin Pharmacol; 1987 Dec; 24(6):729-34. PubMed ID: 2894217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
    Brater DC; Anderson S; Kaplan NM; Ram CV
    J Hypertens; 1984 Feb; 2(1):43-8. PubMed ID: 6152277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.